Leukemia Clinical Trial
Official title:
Improving Communication With and Building a Stronger Medical Home Among Spanish-speaking Families in the Center for Cancer and Blood Disorders
This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | November 4, 2025 |
Est. primary completion date | November 4, 2024 |
Accepts healthy volunteers | |
Gender | All |
Age group | N/A to 22 Years |
Eligibility | Inclusion Criteria: - 0 to 22 years of age - Diagnosis of leukemia or non-Hodgkin lymphoma - Spanish as preferred language for patient, parent or guardian - Received or receiving care at the Center for Cancer and Blood Disorders (CCBD) Exclusion Criteria: - Patients without oncologic diagnosis - Patients with parents whose language preference is English - Patients who received care solely outside of the CCBD |
Country | Name | City | State |
---|---|---|---|
United States | Children's Hospital Colorado | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver | Children's Hospital Colorado |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Determine a baseline level of Spanish speaking patient satisfaction of care | Understand the patient experience using qualitative interview of Spanish speaking patients and families Determine satisfaction based on open-ended question with unsatisfied to satisfied as markers. | 12 months | |
Primary | Determine a baseline level of Spanish Speaking family satisfaction of care | Understand the patient experience using qualitative interview of Spanish speaking patients and families Determine satisfaction based on open-ended question with unsatisfied to satisfied as markers. | 12 months | |
Primary | Determine effects of language barrier on Spanish speaking patient needs | Understand the patient experience using qualitative interview of Spanish speaking patients and families.
Determine satisfaction based on open-ended question to determine a list or pattern of common patient needs. |
12 months | |
Primary | Determine the effect of language barrier on barriers to patient care | Understand the patient experience using qualitative interview of Spanish speaking patients and families.
Determine satisfaction based on open-ended question to determine a list or pattern of common barriers to patient care. |
12 months | |
Primary | Effect of language barrier on efficiency of access to care | Understand the patient experience using qualitative interview of Spanish speaking patients and families.
Determine satisfaction based on open-ended question to determine how quickly patient was able to receive care. |
12 months | |
Secondary | Determine patient interest in home telemedicine support program | Open-ended questions will be used to determine level of interest in a telemedicine support program. | 12 months | |
Secondary | Determine patient interest in home telemedicine support program after discharge | Open-ended questions will be used to determine level of interest in a telemedicine support program to be used after discharge from hospital. | 12 months | |
Secondary | Determine Spanish speaking patient interest in telemedical check-ins during intensive phases of therapy | Open-ended questions will be used to determine level of interest in a telemedical support during treatment. | 12 months | |
Secondary | Determine Spanish speaking patient interest in medication assistance during intensive phases of therapy | Open-ended questions will be used to determine level of interest in a telemedical medication support during therapy. | 12 months | |
Secondary | Determine Spanish speaking patient interest in medical check-ins during maintenance | Open-ended questions will be used to determine level of interest in a telemedical check-ins during maintenance. | 12 months | |
Secondary | Determine Spanish speaking patient interest in medication assistance during maintenance | Open-ended questions will be used to determine level of interest in a telemedical medication assistance during maintenance. | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05691608 -
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
|
N/A | |
Recruiting |
NCT04092803 -
Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu
|
N/A | |
Active, not recruiting |
NCT02530463 -
Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
|
Phase 2 | |
Completed |
NCT00948064 -
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
|
Phase 2 | |
Completed |
NCT04474678 -
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
|
N/A | |
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Recruiting |
NCT03948529 -
RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation
|
Phase 2 | |
Completed |
NCT01682226 -
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
|
Phase 2 | |
Completed |
NCT00003270 -
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
|
Phase 2 | |
Active, not recruiting |
NCT02723994 -
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
|
Phase 2 | |
Terminated |
NCT02469415 -
Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)
|
Phase 2 | |
Recruiting |
NCT04856215 -
90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia
|
Phase 2 | |
Recruiting |
NCT06155188 -
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
|
N/A | |
Completed |
NCT00001637 -
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
|
Phase 2 | |
Active, not recruiting |
NCT04188678 -
Resiliency in Older Adults Undergoing Bone Marrow Transplant
|
N/A | |
Completed |
NCT02910583 -
Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)
|
Phase 2 | |
Completed |
NCT01212926 -
Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain
|
N/A | |
Terminated |
NCT00014560 -
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Recruiting |
NCT04977024 -
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
|
Phase 2 | |
Recruiting |
NCT05866887 -
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
|
N/A |